IL109158A0 - Radiolabeled platelet gpiib/iiia receptor antagonists for use as imaging agents for the diagnosis of thromboembolic disorders - Google Patents

Radiolabeled platelet gpiib/iiia receptor antagonists for use as imaging agents for the diagnosis of thromboembolic disorders

Info

Publication number
IL109158A0
IL109158A0 IL10915894A IL10915894A IL109158A0 IL 109158 A0 IL109158 A0 IL 109158A0 IL 10915894 A IL10915894 A IL 10915894A IL 10915894 A IL10915894 A IL 10915894A IL 109158 A0 IL109158 A0 IL 109158A0
Authority
IL
Israel
Prior art keywords
diagnosis
receptor antagonists
imaging agents
thromboembolic disorders
iiia receptor
Prior art date
Application number
IL10915894A
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/218,861 external-priority patent/US5879657A/en
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of IL109158A0 publication Critical patent/IL109158A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008Peptides; Proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
IL10915894A 1993-03-30 1994-03-29 Radiolabeled platelet gpiib/iiia receptor antagonists for use as imaging agents for the diagnosis of thromboembolic disorders IL109158A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4033693A 1993-03-30 1993-03-30
US08/218,861 US5879657A (en) 1993-03-30 1994-03-28 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders

Publications (1)

Publication Number Publication Date
IL109158A0 true IL109158A0 (en) 1994-10-07

Family

ID=26716976

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10915894A IL109158A0 (en) 1993-03-30 1994-03-29 Radiolabeled platelet gpiib/iiia receptor antagonists for use as imaging agents for the diagnosis of thromboembolic disorders

Country Status (1)

Country Link
IL (1) IL109158A0 (en)

Similar Documents

Publication Publication Date Title
GR3034272T3 (en) RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
GB9020051D0 (en) Muscarinic receptor antagonists
EP0767792A4 (en) Vitronectin receptor antagonists
MA24361A1 (en) PROCESS FOR THE PREPARATION OF VITRONECTIN RECEPTOR ANTAGONISTS
ZA917695B (en) Fibrinogen receptor antagonists
EP0667773A4 (en) Fibrinogen receptor antagonists.
MXPA03009644A (en) 1 substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor antagonists).
PL352100A1 (en) Antagonists of the beta 2 adrenoreceptor
IL125030A0 (en) Vitronectin receptor antagonists
EP0866705A4 (en) Fibrinogen receptor antagonists
EP0912175A4 (en) Fibrinogen receptor antagonists
HU9503402D0 (en) Neurokinin receptor antagonists
EP0796098A4 (en) Fibrinogen receptor antagonists
MXPA94006948A (en) Epibatidine and by-products thereof as agonists and antagonists of the cholinergic receptor.
IL135863A0 (en) Cyclopentene derivatives useful as antagonists of the motilin receptor
HK1018274A1 (en) Oxa- and thia-diazole muscarinic receptor antagonists
IL109158A0 (en) Radiolabeled platelet gpiib/iiia receptor antagonists for use as imaging agents for the diagnosis of thromboembolic disorders
GB9320799D0 (en) Fibrinogen receptor antagonists
GB9515852D0 (en) Fibrinogen receptor antagonists
HRP960237A2 (en) Improved isoxazoline fibrinogen receptor antagonists
DK0789701T3 (en) Substituted tetracyclic azepine derivatives with 5-HT 2 receptor affinity
FR2547183B3 (en) ARTICULATING MECHANISM FOR TWO FOLDABLE SEAT OR BED-DIVAN ELEMENTS
EP0800395A4 (en) Fibrinogen receptor antagonists
GEP19991861B (en) Radiolabeled Platelet GPIIb/IIIa Receptor Antagonists as Imaging Agents for the Diagnosis of Thromboembolic Disorders
HRP980066B1 (en) Sulfonamide substituted compounds, processes for their preparation, their use as medicins or diagnostic agents as well as the medicine containing them